Report Library
View More
Datamonitor Healthcare Oncology: Sa...
May 26, 2023
Datamonitor Healthcare Oncology: Ho...
May 26, 2023
Ovarian Cancer KOL Interview - US, ...
May 25, 2023
Ovarian Cancer KOL Interview - US, ...
May 24, 2023
Ovarian Cancer KOL Interview - Fran...
May 24, 2023
Datamonitor Healthcare CNS Disease ...
May 24, 2023
Datamonitor Healthcare CV&Met: Syst...
May 24, 2023
Datamonitor Healthcare CV&Met: Coro...
May 24, 2023
Datamonitor Healthcare Respiratory:...
May 23, 2023
Datamonitor Healthcare CNS: Neuropa...
May 23, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/25/23 | Artiva Biotherapeutics | AB-101 (Artiva) for Non-Hodgkin's Lymphoma (NHL) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/23 | Merck (MRK) | Reblozyl for Myelodysplastic Syndrome (MDS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/23 | AstraZeneca (AZN) | Imjudo for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/23 | Roche (RHHBY) | Tecentriq for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/23 | Bristol Myers Squibb (BMY) | Breyanzi for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 05/26/23 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (U.S.) |
| 05/27/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/27/23 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
| Now - 05/30/23 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| Now - 05/30/23 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Japan) |
